Margaret Hamburg Remarks on Counterfeit Perscription Drugs
Food and Drug Administration (FDA) Commissioner Margaret Hamburg gave her assessment of the problem of counterfeit…
| Clip Of Drug Safety and Security
This clip, title, and description were not created by C-SPAN.
Report Video IssueUser Clip: PhRMA and GPhA RxTEC Part 2
User-Created Clip
October 3, 2012 2012-09-28T13:55:38-04:00https://images.c-span.org/Files/fea/20120928135614003.jpgPhRMA and GPhA CEO's say they have bi-partisan and bi-cameral commitment for the passing of the Pharmaceutical Traceability Enhancement Code (RxTEC) Act - Part 2
October 3, 2012 2012-09-28T13:55:38-04:00https://images.c-span.org/Files/fea/20120928135614003.jpgPhRMA and GPhA CEO's say they have bi-partisan and bi-cameral commitment for the passing of the Pharmaceutical Traceability Enhancement Code (RxTEC) Act - Part 2
PhRMA and GPhA CEO's say they have bi-partisan and bi-cameral commitment for the passing of the Pharmaceutical Traceability Enhancement Code (RxTEC) Act - Part 2
Hosting Organization
More Videos From
Partnership for Safe Medicines: 3rd Annual Counterfeit Drug Conference
- Technological Strategies For Safe Medicine Use
- John Roth Remarks
- Drug Safety and Security
- International Anti-Counterfeit Prescription Drug Efforts
- Margaret Hamburg Remarks
- Counterfeit Prescription Drugs Conference, Closing Remarks
Purchase a Download
User Clip: PhRMA and GPhA RxTEC Part 2
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
-
Problem of Counterfeit Prescription Drugs
The Partnership for Safe Medicines held a forum on counterfeit prescription drugs. Scott LaGanga opened the discussion with an overview…
-
John Roth Remarks
John Roth, Director of the U.S. Food and Drug Administration’s Office of Criminal Investigations talked about the resources…
-
Technological Strategies For Safe Medicine Use
Panelists talked about the need for technical solutions to the counterfeit drug problem, and the standardization of…
User Created Clips from This Video
-
- 46 minutes
- 30 views
-
- 1 minute
- 22 views
-
- 1 minute
- 22 views